“Soleus Capital, LLC”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  4/16/24  as  ↓Group Member

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Soleus Capital, LLC” has been a Group Member with  3  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
4/16/24		CT	Soleus Private Equity Fund I, L.P.	11	SC 13D/A	CA	BioAtla, Inc.
2/9/24			Soleus Capital Master Fund, L.P.	50	SC 13G/A	MN	Celcuity Inc.
2/6/24		CT	Soleus Private Equity Fund III, L.P.	5	SC 13G/A	CA	Harpoon Therapeutics, Inc.

“Soleus Capital, LLC” has/had a Group Member interest in  24  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
4/16/24		CA	BioAtla, Inc.	5	SC 13D/A	CT	Soleus Private Equity Fund I, L.P.
2/9/24		MN	Celcuity Inc.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/8/24		CA	CalciMedica, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/6/24		CA	Harpoon Therapeutics, Inc.	2	SC 13G/A	CT	Soleus Private Equity Fund III, L.P.
2/6/24			Mereo BioPharma Group plc	2	SC 13G/A	CT	Soleus Private Equity Fund III, L.P.
2/5/24		MA	C4 Therapeutics, Inc.	3	SC 13G		Soleus Capital Master Fund, L.P.
2/2/24		MA	Pieris Pharmaceuticals, Inc.	4	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		CA	Rigel Pharmaceuticals Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		MA	Organogenesis Holdings Inc.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		MN	Surmodics Inc.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		CA	Jasper Therapeutics, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		MA	Verastem, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		FL	Iradimed Corp.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		NJ	VYNE Therapeutics Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24			Edap TMS SA	5	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		NY	Delcath Systems, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		FL	Axogen, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		CA	NeuroPace Inc.	4	SC 13G/A	CT	Soleus Private Equity Fund I, L.P.
1/10/24		NY	Immunic, Inc.	1	SC 13G	CT	Soleus Private Equity Fund III, L.P.
11/28/23			Theratechnologies Inc.	5	SC 13D		Soleus Capital Master Fund, L.P.
			More...  Please Sign In to list all 24 of them.

“Soleus Capital, LLC” has been a Group Member with  12  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
4/16/24		CT	Guy Levy	66	SC 13D/A	CT	Soleus Private Equity Fund I, L.P.	CA	BioAtla, Inc.
		CT	Soleus Capital Group, LLC	66
			Soleus Capital Master Fund, L.P.	16
		CT	Soleus Pe GP I, LLC	11
		CT	Soleus Private Equity GP I, LLC	11
2/9/24		•	Soleus Pe GP II, LLC	3	SC 13G/A		Soleus Capital Master Fund, L.P.	MN	Celcuity Inc.
		CT	Soleus Private Equity Fund II, L.P.	3
		•	Soleus Private Equity GP II, LLC	3
2/8/24		•	Soleus Pe GP III, LLC	9	SC 13G/A		Soleus Capital Master Fund, L.P.	CA	CalciMedica, Inc.
		CT	Soleus Private Equity Fund III, L.P.	4
		•	Soleus Private Equity GP III, LLC	9
1/9/23		CT	Soleus Ba SPV, LLC	4	SC 13D/A	CT	Soleus Private Equity Fund I, L.P.	CA	BioAtla, Inc.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Soleus Capital, LLC” has been a Signatory for/with  4  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
4/9/24		CO	Biodesix Inc.	1	8-K	—
3/28/24		MA	CervoMed Inc.	1	8-K	—
4/13/22		MA	Lyra Therapeutics, Inc.	1	8-K	—
5/5/21		FL	Neogenomics Inc.	1	8-K	—